Catalyst Pharmaceuticals
CPRX
#3910
Rank
C$3.43 B
Marketcap
$28.96
Share price
4.50%
Change (1 day)
69.97%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): C$0.12 B

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings (TTM) are C$0.12 B. In 2023 the company made an earning of C$0.12 B a decrease over its 2022 earnings that were of C$0.14 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.12 B-1.66%
2023 C$0.12 B-9.75%
2022 C$0.14 B98.83%
2021 C$71.43 M25.73%
2020 C$56.81 M25.38%
2019 C$45.31 M-198.25%
2018 -C$46.13 M84.68%
2017 -C$24.98 M1.88%
2016 -C$24.52 M-10.68%
2015 -C$27.45 M30.46%
2014 -C$21.04 M27.6%
2013 -C$16.49 M198.17%
2012 -C$5.53 M-36.22%
2011 -C$8.67 M59.52%
2010 -C$5.44 M-44.68%
2009 -C$9.83 M-31.45%
2008 -C$14.33 M155.21%
2007 -C$5.62 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$0.40 B 219.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.39 M-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.49 B 21,567.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.37 B-390.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.65 B-1,395.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.82 B 6,856.81%๐Ÿ‡บ๐Ÿ‡ธ USA